The effects of RO-22-4679, a thromboxane synthetase inhibitor, on ventricular fibrillation induced by coronary artery occlusion in conscious dogs.
D000818:Animals; D001792:Blood Platelets / Q000502:physiology; D003327:Coronary Disease / Q000150:complications*; D004285:Dogs; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D007093:Imidazoles / Q000494:pharmacology*; D009203:Myocardial Infarction / Q000209:etiology; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D010974:Platelet Aggregation; D012039:Regional Blood Flow; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*; D014693:Ventricular Fibrillation / Q000209:etiology / Q000517:prevention & control*
D004791:Enzyme Inhibitors; D007093:Imidazoles; C038205:Ro 22-4679; D010088:Oxidoreductases; D013930:Thromboxane-A Synthase